Radiotherapy and Tumor Treating Fields for human Glioblastoma Cells: Does the Treatment Sequence play a Role?

被引：0
|
作者：
Goett, H. [1 ]
Salvers, P. [1 ]
Jensen, A. [2 ]
Kolodziej, M. [1 ]
Uhl, E. [1 ]
Stein, M. [1 ]
机构：
[1] Univ Klinikum Giessen, Klin Neurochirurg, Giessen, Germany
[2] Univ Klinikum Giessen, Klin Strahlentherapie, Giessen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2021年 / 197卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-28
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [41] TUMOR TREATING FIELDS AND RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY AND EFFICACY RESULTS FROM A PILOT STUDY
    Grossman, Rachel
    Bokstein, Felix
    Blumenthal, Deborah
    Ben Harush, Carmit
    Limon, Dror
    Ram, Zvi
    NEURO-ONCOLOGY, 2018, 20 : 144 - 144
  • [42] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Almuth F. Kessler
    Greta E. Frömbling
    Franziska Gross
    Mirja Hahn
    Wilfrid Dzokou
    Ralf-Ingo Ernestus
    Mario Löhr
    Carsten Hagemann
    Cell Death Discovery, 4
  • [43] A FGFR1 INHIBITION SENSITIZES GLIOBLASTOMA STEM CELLS TO TUMOR TREATING FIELDS
    Gouaze-Andersson, V
    Deshors, P.
    Cohen-Jonathan Moyal, E.
    NEURO-ONCOLOGY, 2024, 26
  • [44] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Kessler, Almuth F.
    Froembling, Greta E.
    Gross, Franziska
    Hahn, Mirja
    Dzokou, Wilfrid
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    CELL DEATH DISCOVERY, 2018, 4
  • [45] PROSTAGLANDIN E RECEPTOR 3 MEDIATES RESISTANCE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA CELLS
    Chen, Dongjiang
    Le, Son
    Thomas, Nagheme
    Tran, David
    NEURO-ONCOLOGY, 2019, 21 : 72 - 72
  • [46] Prostaglandin E receptor 3 mediates resistance to tumor treating fields in glioblastoma cells
    Chen, Dongjiang
    Le, Son
    Thomas, Nagheme
    Deng, Changwang
    Jin, Dan
    Sebstian, Mathew
    Ren, Jie
    Tran, David
    CANCER RESEARCH, 2019, 79 (13)
  • [47] Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis
    Regev, Ohad
    Merkin, Vladimir
    Blumenthal, Deborah T.
    Melamed, Israel
    Kaisman-Elbaz, Tehila
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (04) : 426 - 440
  • [48] CLINICAL AND SOCIAL CHALLENGES & OPPORTUNITIES IN TREATING GLIOBLASTOMA WITH TUMOR TREATMENT FIELDS, A CASE SERIES
    Nguyen, Minhdan
    Truong, Judy
    Saria, Marlon
    Kesari, Santosh
    NEURO-ONCOLOGY, 2017, 19 : 204 - 204
  • [49] Concomitant dexamethasone treatment and tumor treating fields induced cell death in glioblastoma.
    Schiesl, Abigail
    Linder, Benedikt
    Roedel, Franz
    Hehlgans, Stephanie
    Guelluelue, Oemer
    Seifert, Volker
    Koegel, Donat
    Senft, Christian
    Dubinski, Daniel
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies
    Mittal, Sandeep
    Klinger, Neil V.
    Michelhaugh, Sharon K.
    Barger, Geoffrey R.
    Pannullo, Susan C.
    Juhasz, Csaba
    JOURNAL OF NEUROSURGERY, 2018, 128 (02) : 414 - 421
12345